These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7448010)

  • 1. [Phospholipidosis induced by chlorimipramine in rat lung].
    Gremigni D; Vannelli G; Sgaragli GP; Mengazzini I
    Boll Soc Ital Biol Sper; 1980 May; 56(10):1078-82. PubMed ID: 7448010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled cationic amphiphilic drug-induced pulmonary phospholipidosis in rats and dogs: time-course and dose-response of biomarkers of exposure and effect.
    Pauluhn J
    Toxicology; 2005 Feb; 207(1):59-72. PubMed ID: 15590122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phospholipidosis of the rat lung following administrations of chlorimipramine].
    Gremigni D; Vannelli G; Sgaragli G; Della Corte L
    Arch Ital Anat Embriol; 1981; 86(1-2):37-53. PubMed ID: 7316635
    [No Abstract]   [Full Text] [Related]  

  • 4. Chlorimipramine-induced phospholipidosis: biochemical and pharmacokinetic observations in the rat.
    Sgaragli GP; Della Corte L; Gremigni D
    Pharmacol Res Commun; 1983 Mar; 15(3):231-46. PubMed ID: 6856656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages.
    McCloud CM; Beard TL; Kacew S; Reasor MJ
    Exp Mol Pathol; 1995 Feb; 62(1):12-21. PubMed ID: 7556587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorimipramine-induced phospholipidosis: biochemical and pharmacokinetic observations [proceedings].
    Della Corte L; Gremigni D; Megazzini I; Mobilio R; Sgaragli GP
    Br J Pharmacol; 1979 Nov; 67(3):449P-450P. PubMed ID: 497566
    [No Abstract]   [Full Text] [Related]  

  • 7. Chlorcyclizine--induced pulmonary phospholipidosis in rats.
    Reasor MJ; Heyneman CA; Walker ER
    Res Commun Chem Pathol Pharmacol; 1982 Nov; 38(2):235-46. PubMed ID: 6131507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers to monitor drug-induced phospholipidosis.
    Baronas ET; Lee JW; Alden C; Hsieh FY
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):72-8. PubMed ID: 17156806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental phospholipidosis induced by 4,4'-diethyl-aminoethoxyhexestrol. Morphological and biochemical interpretations.
    Tashiro Y; Watanabe Y; Enomoto Y
    Acta Pathol Jpn; 1983 Sep; 33(5):929-42. PubMed ID: 6316720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphological, histochemical and biochemical changes induced by homochlorcyclizine in the rat].
    Lageron A; Saffroy M
    Acta Histochem; 1982; 71(1):103-10. PubMed ID: 6128854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of surfactant protein SP-A, SP-B, and SP-C mRNA in rat lungs with lipopolysaccharide-induced injury.
    Sugahara K; Iyama K; Sano K; Kuroki Y; Akino T; Matsumoto M
    Lab Invest; 1996 Jan; 74(1):209-20. PubMed ID: 8569184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dynamic change of apoptosis of alveolar cells in ischemia-reperfusion induced pulmonary injury: an experimental study with rats].
    Zhang S; Chen RK; Lin M; He XM
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1597-600. PubMed ID: 15569452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine D3 selective antagonist PNU-177864.
    Rudmann DG; McNerney ME; VanderEide SL; Schemmer JK; Eversole RR; Vonderfecht SL
    Toxicol Pathol; 2004; 32(3):326-32. PubMed ID: 15204974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery from chlorphentermine-induced phospholipidosis in rat alveolar macrophages: morphological features.
    Reasor MJ; Walker ER
    Exp Mol Pathol; 1981 Dec; 35(3):370-9. PubMed ID: 7308413
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development.
    Fujimura H; Dekura E; Kurabe M; Shimazu N; Koitabashi M; Toriumi W
    Exp Toxicol Pathol; 2007 Aug; 58(6):375-82. PubMed ID: 17408938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced phospholipidosis.
    Lüllmann H; Lüllmann-Rauch R; Wassermann O
    Ger Med; 1973; 3(3-4):128-35. PubMed ID: 4370610
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of stone-wool on rat lungs and on the primary culture of rat alveolar macrophages and type II pneumocytes.
    Tátrai E; Brozik M; Drahos A; Kováciková Z; Six E; Csík M; Dám A
    J Appl Toxicol; 2006; 26(1):16-24. PubMed ID: 16173009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone induced phospholipidosis. Biochemical, morphological and functional changes in the lungs of rats chronically treated with amiodarone.
    Riva E; Marchi S; Pesenti A; Bizzi A; Cini M; Veneroni E; Tavbani E; Boeri R; Bertani T; Latini R
    Biochem Pharmacol; 1987 Oct; 36(19):3209-14. PubMed ID: 3663236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural analysis of the type II epithelial cells and free alveolar cells in experimental lung emphysema.
    Sulkowski ST
    Pol J Pathol; 1994; 45(1):63-71. PubMed ID: 8177620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipidosis in healthy subjects participating in clinical studies: ultrastructural findings in white blood cells.
    Pospischil A; Walther P; Dingemanse J
    Exp Toxicol Pathol; 2010 Sep; 62(5):567-71. PubMed ID: 19674876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.